For example, KOD’s Tarcocimab Tedromer is an anti-vascular endothelial growth factor [anti-VEGF] antibody biopolymer conjugate that’s currently in Phase 3. This candidate is being tested in ...
Pathogenic variants were then studied in vivo using a transgenic zebrafish model. Conclusions Our study highlights the specific role of BMP/TGF-β and VEGF/VEGFR signalling in the aetiology of BAVM and ...
["MYH9..ENSG0004627", "LMNA..ENSG0004000", "HSPG2..ENSG0003339", "EPHB4..ENSG0002050", "CSMD3..ENSG000114788", "FRMPD2..ENSG000143162", "FNDC3B..ENSG00064778 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback